177 related articles for article (PubMed ID: 25422594)
1. Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.
Liu X; Giguère V
Nucl Recept Signal; 2014; 12():e004. PubMed ID: 25422594
[TBL] [Abstract][Full Text] [Related]
2. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
3. Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis.
Liu X; Nugoli M; Laferrière J; Saleh SM; Rodrigue-Gervais IG; Saleh M; Park M; Hallett MT; Muller WJ; Giguère V
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):774-9. PubMed ID: 21187396
[TBL] [Abstract][Full Text] [Related]
4. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
5. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis.
Jang JW; Boxer RB; Chodosh LA
Mol Cell Biol; 2006 Nov; 26(21):8109-21. PubMed ID: 16908535
[TBL] [Abstract][Full Text] [Related]
8. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
[TBL] [Abstract][Full Text] [Related]
9. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
Lu Y; Bertran S; Samuels TA; Mira-y-Lopez R; Farias EF
Oncogene; 2010 Jun; 29(25):3665-76. PubMed ID: 20453882
[TBL] [Abstract][Full Text] [Related]
12. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
Ford NA; Nunez NP; Holcomb VB; Hursting SD
Endocr Relat Cancer; 2013 Feb; 20(1):39-51. PubMed ID: 23152442
[TBL] [Abstract][Full Text] [Related]
13. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
15. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
Dearth RK; Kuiatse I; Wang YF; Liao L; Hilsenbeck SG; Brown PH; Xu J; Lee AV
BMC Cancer; 2011 Aug; 11():377. PubMed ID: 21867536
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
Bui T; Schade B; Cardiff RD; Aina OH; Sanguin-Gendreau V; Muller WJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E707-E716. PubMed ID: 28096336
[TBL] [Abstract][Full Text] [Related]
17. Proteotypic classification of spontaneous and transgenic mammary neoplasms.
Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP
Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849
[TBL] [Abstract][Full Text] [Related]
18. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
19. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
20. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
